Geode Capital Management
INKT icon

Geode Capital Management’s MiNK Therapeutics INKT Stock Holding History

Geode Capital Management’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$235K Buy
18,759
+3,186
+20% +$36.2K ﹤0.01% 3819
2026
Q2 		$182K Sell
15,573
-1,772
-10% -$20.6K ﹤0.01% 3947
2026
Q1 		$183K Buy
17,345
+3,098
+22% +$34.5K ﹤0.01% 3939
2025
Q4 		$159K Buy
14,247
+1,441
+11% +$18.6K ﹤0.01% 3985
2025
Q3 		$179K Buy
12,806
+1,314
+11% +$21K ﹤0.01% 3962
2025
Q2 		$86K Buy
11,492
+238
+2% +$1.79K ﹤0.01% 4102
2025
Q1 		$97.3K Buy
11,254
+1,643
+17% +$14.6K ﹤0.01% 4039
2024
Q4 		$67K Sell
9,611
-187
-2% -$1.27K ﹤0.01% 4190
2024
Q3 		$73.5K Buy
9,798
+163
+2% +$1.38K ﹤0.01% 4178
2024
Q2 		$91.5K Buy
9,635
+749
+8% +$7.29K ﹤0.01% 4161
2024
Q1 		$80.7K Sell
8,886
-130
-1% -$1.21K ﹤0.01% 4226
2023
Q4 		$96.9K Hold
9,016
– – ﹤0.01% 4196
2023
Q3 		$106K Sell
9,016
-256
-3% -$4.17K ﹤0.01% 4231
2023
Q2 		$195K Buy
9,272
+6,742
+266% +$135K ﹤0.01% 4057
2023
Q1 		$48.6K Hold
2,530
– – ﹤0.01% 4527
2022
Q4 		$65K Buy
2,530
+212
+9% +$4.98K ﹤0.01% 4520
2022
Q3 		$48K Hold
2,318
– – ﹤0.01% 4775
2022
Q2 		$32K Sell
2,318
-1,072
-32% -$20.2K ﹤0.01% 4860
2022
Q1 		$76K Buy
3,390
+1,032
+44% +$31K ﹤0.01% 4728
2021
Q4 		$105K Buy
+2,358
New +$280K ﹤0.01% 4717

Other funds holding INKT

US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Paladin Partners
Paladin Partners Hartland, Wisconsin $162M AUM 13.31% 1-Year Est. Return
Covestor
Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Key Financial Inc
Key Financial Inc West Chester, Pennsylvania $614M AUM 14.43% 1-Year Est. Return

Geode Capital Management's INKT Position: Q3 2026 in Review

Geode Capital Management increased its MiNK Therapeutics (INKT) stake by 20% in Q3 2026, buying an estimated $36.2K and bringing the position to 18,759 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #3819.

Geode Capital Management first reported a position in INKT in Q4 2021 and has held it in 20 quarters since. 7 funds tracked by Wall St. Rank hold INKT as of Q3 2026.

  • Geode Capital Management held 18,759 shares of MiNK Therapeutics worth $235K as of Q3 2026.
  • Geode Capital Management bought 3,186 MiNK Therapeutics shares in Q3 2026, an estimated $36.2K.
  • MiNK Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3819 holding.
  • Geode Capital Management first reported a position in MiNK Therapeutics in Q4 2021 and has held it in 20 quarters since.
  • 7 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.